No Photo Available

Last Update

2016-12-31T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Neil Berinstein?

Dr. Neil L. Berinstein

Medical Oncologist

Odette Cancer Centre of the Sunnybrook Health Sciences Centre

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Odette Cancer Centre of the Sunnybrook Health Sciences Centre

Background Information

Employment History

Professor, Department of Immunology

University of Toronto

Cancer Researcher and Clinician Scientist

Sunnybrook Health Sciences Centre

Assistant Vice President and Global Program Leader

Sanofi Pasteur Limited

Vice President

CANVAC

Affiliations

Part of the Executive Steering Committee
Cancer Research Institute

Science Advisory Board
ImmunoVaccine Technologies Inc.

Scientific Advisory Board Member
Biovest International , Inc.

Scientific Advisor
Spectrum

Scientific Advisory Board Member
Molecular Templates Inc

Advisory Boards Member
Phacilitate Limited

Board Member
Canadian Blood and Marrow Transplant Group

Full Member
School of Graduate Studies

Co-Founder
Hope for Health Foundation

Member
Leukemia Research Fund

Scientific Advisory Board Member
Accentia Biopharmaceuticals , Inc.

Post-Doctoral Fellow
Stanford University

Education

Internal Medicine and Medical Oncology

University of Toronto

M.D.

Department of Medicine

MD

University of Manitoba

Medical Doctoral Degree

University of Manitoba

pre-medical degree

University of Manitoba

premedical degree

University of Manitoba

Web References (137 Total References)


About IRX - IRX Therapeutics

irxtherapeutics.com [cached]

Neil L. Berinstein, MD, FRCP(C), ABIM

Neil L. Berinstein, MD, FRCP(C), ABIM was appointed Chief Scientific Advisor in January 2010. Prior to joining IRX Therapeutics, Dr. Berinstein served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, where he was in charge of leading the development of Sanofi's cancer vaccines both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with Sanofi Pasteur either at preclinical or clinical levels. He saw to completion several multicenter phase 1 and phase 2 studies in Canada and the US in colorectal and melanoma projects.
Dr. Berinstein currently holds multiple academic and professional positions, including Professor in the Department of Medicine, University of Toronto, and Affiliate Scientist, Biological Sciences at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre, Toronto. He was the Vice President of the Cancer Vaccine Consortium sponsored by the Sabin Institute and more recently is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Vaccine Consortium. He was formerly a member and leader of the scientific review committee of the Leukemia Research Fund.
Dr. Berinstein has been the recipient of numerous grants in his research career and has published 6 book chapters, and over 100 peer-reviewed, invited or review papers to date. He received his premedical degree and Medical Doctorate from the University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.


New Treatment Perspectives in CLL: Using Disease and Patient Characteristics to Optimize Outcomes | New Evidence

www.newevidence.com [cached]

Neil Berinstein, MD Dr. Neil Berinstein earned his pre-medical degree and Medical Doctorate from the University of Manitoba and received further specialty and research training at the University of Toronto and Stanford University. Dr. Berinstein currently holds multiple academic and professional positions, including as a Professor in the Department of Medicine at the University of Toronto, and he is on the active staff of the Hematology Oncology Site Group at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre. He is currently the Director of Translational Research at the Ontario Institute for Cancer Research. Dr. Berinstein specializes in the management and research of patients with lymphoproliferative disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Hodgkin lymphoma, and myeloma. Dr. Berinstein has received numerous grants throughout his career for his research, which focuses on the development of novel immunotherapeutic and targeted approaches for cancer and hematologic malignancies. He has published six book chapters and over 100 peer-reviewed, invited, or review papers.


There is a clear and important ...

www.dddmag.com [cached]

There is a clear and important unmet medical need in this area of lymphoma management and we are eager to evaluate the potential of this combination therapy to deliver clinical benefit to those patients," said Neil Berinstein, M.D., professor, Department of Medicine at the University of Toronto and medical oncologist at the Odette-Sunnybrook Cancer Centre, one of the sites at which the lymphoma trial will be conducted.


Immunovaccine : Press Releases

www.imvaccine.com [cached]

There is a clear and important unmet medical need in this area of lymphoma management and we are eager to evaluate the potential of this combination therapy to deliver clinical benefit to those patients," said Neil Berinstein, M.D., Professor, Department of Medicine at the University of Toronto and medical oncologist at the Odette-Sunnybrook Cancer Centre, one of the sites at which the lymphoma trial will be conducted.


Dr. Neil ...

dermatologyupdate.com [cached]

Dr. Neil Berinstein

...
Dr. Neil Berinstein
...
Dr. Neil Berinstein
...
Dr. Neil Berinstein
Oncologist, Toronto, Ontario, Canada
Dr. Neil Berinstein is the Global Head of the Cancer Vaccine Program at Sanofi-Pasteur, Toronto-Sunnybrook Regional Cancer Centre. His research interests include immunotherapy in the treatment of cancer.

Similar Profiles

Other People with this Name

Other people with the name Berinstein

Dori Berinstein
Dramatists Play Service , Inc.

Carolina Berinstein
Sherbourne Health Centre

Jenna Berinstein
Charles E. Smith Jewish Day School

Eduardo Berinstein
Boston University

Corinne Berinstein
Ingredion Canada Incorporated

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory